Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SGMO
SGMO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SGMO News
Sangamo Reports Positive Data for Fabry Disease Treatment
Feb 04 2026
NASDAQ.COM
Sangamo Therapeutics Shares Plunge Over 31%
Feb 03 2026
Yahoo Finance
Sangamo Therapeutics Shares Plunge 28% After $25M Stock Offering
Feb 03 2026
seekingalpha
Sangamo Therapeutics Announces Pricing of Stock Offering
Feb 03 2026
Newsfilter
Sangamo Initiates BLA Submission for ST-920, Expected in Q2 2026
Dec 18 2025
Globenewswire
Sangamo Initiates BLA Submission for ST-920, Expected Completion in Q2 2026
Dec 18 2025
Newsfilter
Sangamo Receives FDA Fast Track Designation for ST-503 in Chronic Pain Treatment
Dec 02 2025
Globenewswire
Sangamo Soars After FDA Awards Fast Track Designation to Neuropathic Pain Treatment
Dec 02 2025
SeekingAlpha
Sangamo Receives FDA Acceptance for Gene Therapy BLA Submission
Nov 24 2025
Newsfilter
FDA Approves Sangamo's Proposal for Rolling BLA Submission of Gene Therapy Candidate for Fabry Disease
Nov 21 2025
NASDAQ.COM
Sangamo Shares Climb Following FDA's Acceptance of Gene Therapy Rolling Submission Request
Nov 21 2025
SeekingAlpha
VTI ETF Daily Briefing: Key Information for Investors – November 7, 2025
Nov 07 2025
TipRanks
CarMax Analyst Changes Stance; Check Out the Top 5 Downgrades for Friday
Nov 07 2025
Benzinga
Sangamo aims for Q1 2026 BLA filing for Fabry gene therapy as FDA confirms expedited process
Nov 06 2025
SeekingAlpha
Sangamo (SGMO) Third Quarter 2025 Earnings Call Summary
Nov 06 2025
NASDAQ.COM
Sangamo Therapeutics Shares Decline Following CFO Retirement Announcement
Sep 12 2025
SeekingAlpha
Show More News
